Dang, Le Hang’s team published research in Bulletin of Materials Science in 2019 | CAS: 156-87-6

3-Aminopropan-1-ol(cas: 156-87-6) belongs to anime. Halogenation, in which one or more hydrogen atoms of an amine is replaced by a halogen atom, occurs with chlorine, bromine, and iodine, as well as with some other reagents, notably hypochlorous acid (HClO). With primary amines the reaction proceeds in two stages, producing N-chloro- and N,N-dichloro-amines, RNHCl and RNCl2, respectively. With tertiary amines, an alkyl group may be displaced by a halogen.COA of Formula: C3H9NO

In 2019,Bulletin of Materials Science included an article by Dang, Le Hang; Huynh, Ngoc Trinh; Pham, Ngoc Oanh; Nguyen, Cong Truc; Vu, Minh Thanh; Dinh, Van Thoai; Le, Van Thu; Tran, Ngoc Quyen. COA of Formula: C3H9NO. The article was titled 《Injectable nanocurcumin-dispersed gelatin-pluronic nanocomposite hydrogel platform for burn wound treatment》. The information in the text is summarized as follows:

To utilize the potent pharmaceutical properties of curcumin (Cur) and gelatin-based materials in tissue regeneration, we fabricated a thermosensitive nanocomposite hydrogel based on pluronic-grafted gelatin (PG) and nanocurcumin (nCur) to enhance burn healing. In this method, the amphiphilic PG played a role as a surfactant to prepare and protect nanosized Cur particles, which could overcome the poor dissolution of the phytochem. The synthesized PG was identified by 1H NMR. Depending on the amount of Cur, size distribution of the dispersed nCur ranged from 1.5 ± 0.5 to 16 ± 3.2 nm as observed using transmission electron microscopy and dynamic light scattering. The nCur-dispersed PG solution formed nCur-PG nanocomposite hydrogel on warming up to 35oC. Release profile indicated sustainable release of Cur from the injectable platform. Fibroblast cells were well proliferated on the nanocomposite hydrogel. The nCur-PG enhanced the healing process of second-degree burn wound. These results showed potential applications of the biomaterial in tissue regeneration. The experimental process involved the reaction of 3-Aminopropan-1-ol(cas: 156-87-6COA of Formula: C3H9NO)

3-Aminopropan-1-ol(cas: 156-87-6) belongs to anime. Halogenation, in which one or more hydrogen atoms of an amine is replaced by a halogen atom, occurs with chlorine, bromine, and iodine, as well as with some other reagents, notably hypochlorous acid (HClO). With primary amines the reaction proceeds in two stages, producing N-chloro- and N,N-dichloro-amines, RNHCl and RNCl2, respectively. With tertiary amines, an alkyl group may be displaced by a halogen.COA of Formula: C3H9NO

Referemce:
Alcohol – Wikipedia,
Alcohols – Chemistry LibreTexts

Khan, Ayesha’s team published research in Medicinal Chemistry Research in 2019 | CAS: 26153-38-8

3,5-Dihydroxybenzaldehyde(cas: 26153-38-8) is used as a building block in the synthesis of more complex structures. It is also used in the synthesis of terbutaline, which is an important bronchodilator.Quality Control of 3,5-Dihydroxybenzaldehyde

In 2019,Medicinal Chemistry Research included an article by Khan, Ayesha; Khan, Ajmal; Farooq, Umar; Taha, Muhammad; Shah, Syed Adnan Ali; Halim, Sobia Ahsan; Akram, Arfa; Khan, Mohammed Ziauddin; Jan, Abdul Khaliq; Al-Harrasi, Ahmed. Quality Control of 3,5-Dihydroxybenzaldehyde. The article was titled 《Oxindole-based chalcones: synthesis and their activity against glycation of proteins》. The information in the text is summarized as follows:

Diabetes mellitus, a metabolic disorder, is characterized by a substantial hyperglycemia. Prevalence of hyperglycemia for longer period of time can cause nonenzymic condensation of sugar in blood with amino group of protein and give rise to advanced glycation end products (AGEs). AGEs play a major role in the onset of late diabetic complications including diabetic retinopathy, nephropathy, neuropathy and cardiovascular diseases. There is a need to establish potential therapeutic regimens that can effectively inhibit the formation of AGEs. To this end a series of novel oxindole-based chalcones have been investigated for their antiglycation potential. Analogs 1 (IC50 = 155.22 ± 2.98 μM), 3 (IC50 = 195.95 ± 0.43 μM), 4 (IC50 = 289.47 ± 2.47 μM), 5 (IC50 = 222.44 ± 4.03 μM), 7 (IC50 = 251.27 ± 2.80 μM), and 20 (224.23 ± 1.93 μM) showed potent inhibitory activity against glycation compared to the reference Rutin (IC50 = 294.5 ± 1.5 μM). These results reveal that multiple hydroxyl substituents and their position on the aromatic ring play a key role in inhibitory effect due to their hydrogen bonding potential. The study also reveals the influence of substituents on the binding capabilities and in turn inhibitory potential of different analogs.3,5-Dihydroxybenzaldehyde(cas: 26153-38-8Quality Control of 3,5-Dihydroxybenzaldehyde) was used in this study.

3,5-Dihydroxybenzaldehyde(cas: 26153-38-8) is used as a building block in the synthesis of more complex structures. It is also used in the synthesis of terbutaline, which is an important bronchodilator.Quality Control of 3,5-Dihydroxybenzaldehyde

Referemce:
Alcohol – Wikipedia,
Alcohols – Chemistry LibreTexts

Liu, Qun’s team published research in Polymer Degradation and Stability in 2019 | CAS: 4048-33-3

6-Aminohexan-1-ol(cas: 4048-33-3) may be used along with glutaric acid to generate poly(ester amide)s with excellent film- and fiber forming properties. It can undergo cyclization over copper supported on γ-alumina and magnesia to form hexahydro-1H-azepine.COA of Formula: C6H15NO

The author of 《Enzymatic degradation of fluorinated Poly(ε-caprolactone) (PCL) block copolymer films with improved hydrophobicity》 were Liu, Qun; Wang, Haipeng; Chen, Lei; Li, Wulong; Zong, Yakun; Sun, Yi; Li, Zhanxiong. And the article was published in Polymer Degradation and Stability in 2019. COA of Formula: C6H15NO The author mentioned the following in the article:

Fluorinated Poly(ε-caprolactone) (PCL) block copolymers PCL-PTFOA(2 h), PCL-PTFOA(4 h), PCL-PTFOA(6 h), PCL-PTFOA(8 h) were prepared via esterification by using poly(1H,1H,2H,2H-perfluorooctylacrylate) (PTFOA) with different mol. weights as reactants. It was found that PCL-PTFOA(6 h) and PCL-PTFOA(8 h) possessed the similar mol. weight via GPC anal. PCL and fluorinated PCL block copolymers films were prepared by solution casting method. The structure and properties of film surface of the fluorinated PCL block copolymers were analyzed by energy dispersive X-ray spectrometer (EDS), scanning electron microscope (SEM), Differential scanning calorimetry (DSC), water contact angles (WCAs) and the surface free energy. The results showed that the fluorinated PCL films possessed improved hydrophobicity because of the microphase separation between fluoropolymer chain and PCL chain. The enzymic degradation of PCL, PCL-PTFOA(2 h), PCL-PTFOA(4 h) and PCL-PTFOA(6 h) films were performed at 37 °C in a phosphate buffer solution (PBS, 0.1 M, with a pH of 7.2-7.4) with lipase and analyzed by weight loss, SEM and EDS. It was found that the introduction of fluorine-containing segment reduced the rate of enzymic degradation of the copolymer film in the early period, while increased the finally weight loss rate with a prolonged time. In addition, the enzymic degradation rate of PCL-PTFOA(2 h) film and PCL-PTFOA(4 h) film was faster than that of PCL-PTFOA(6 h) film. The experimental part of the paper was very detailed, including the reaction process of 6-Aminohexan-1-ol(cas: 4048-33-3COA of Formula: C6H15NO)

6-Aminohexan-1-ol(cas: 4048-33-3) may be used along with glutaric acid to generate poly(ester amide)s with excellent film- and fiber forming properties. It can undergo cyclization over copper supported on γ-alumina and magnesia to form hexahydro-1H-azepine.COA of Formula: C6H15NO

Referemce:
Alcohol – Wikipedia,
Alcohols – Chemistry LibreTexts

Nguyen, Van Toan’s team published research in Journal of Nanomaterials in 2019 | CAS: 13325-10-5

4-Aminobutan-1-ol(cas: 13325-10-5) is used in the synthesis of NSAIDs with anti-inflammatory properties. Also used in the synthesis of polyamine transport ligands with specificity against human cancers allowing easy access to specific cancer cells.Reference of 4-Aminobutan-1-ol

The author of 《Folate-conjugated chitosan-pluronic P123 nanogels: synthesis and characterizations towards dual drug delivery》 were Nguyen, Van Toan; Nguyen, Thi Huong; Dang, Le Hang; Vu-Quang, Hieu; Tran, Ngoc Quyen. And the article was published in Journal of Nanomaterials in 2019. Reference of 4-Aminobutan-1-ol The author mentioned the following in the article:

In this study, a self-assembled nanogel-based pluronic P123-grafted chitosan-folate (CP-FA) was fabricated as a paclitaxel/curcumin codelivery system. 1H-NMR and TGA proved that the fabricating method of CP-FA was successful. Dynamic light scattering (DLS), zeta potentials, and transmission electron microscopy (TEM) exposed that CP-FA nanoparticles had a uniform size with a diameter of around 16.27 ± 2.01 nm in the colloidal solution and had better sustainable stability at a lower concentration than P123 due to the moderate pos. potential value (39.43 ± 3.45 mV) and the lower critical micelle concentration (0.036 mg/mL). Dual drugs were loaded with CP-FA nanogels via self-assembly by the hydrophobic interaction between both hydrophobic therapeutic compounds (PTX and Cur) and the hydrophobic segment of the P123 copolymer. The high hydrophobicity of the segment induced a great loading efficacy of up to 98.63 ± 0.42 of PTX and 97.82 ± 0.48 of Cur. In addition, the CP-FA nanogels exposed superior effects in a controlled release of these encapsulated therapeutic compounds for a long period of time. The anticancer activity of the dual-drug delivery system was evaluated using human breast cancer cell lines (MCF-7) via the IC50 value to compare with the PTX-loading CP-FA nanogel. The obtained results suggested that CP-FA/PTX-Cur displayed a remarkable improvement in anticancer activity at an IC50 value of 5.74 ± 0.23 nM which was higher than that of CP-FA/PTX (IC50 = 8.20 ± 1.41 nM) due to the synergistic effect of both PTX and Cur. Thereby, a dual-drug delivery-system-based CP-FA of PTX and Cur has been proposed as a promising candidate in cancer therapy.4-Aminobutan-1-ol(cas: 13325-10-5Reference of 4-Aminobutan-1-ol) was used in this study.

4-Aminobutan-1-ol(cas: 13325-10-5) is used in the synthesis of NSAIDs with anti-inflammatory properties. Also used in the synthesis of polyamine transport ligands with specificity against human cancers allowing easy access to specific cancer cells.Reference of 4-Aminobutan-1-ol

Referemce:
Alcohol – Wikipedia,
Alcohols – Chemistry LibreTexts

Li, Ya’s team published research in ACS Applied Materials & Interfaces in 2019 | CAS: 34374-88-4

2,4,6-Trihydroxybenzene-1,3,5-tricarbaldehyde(cas: 34374-88-4) is a member of phloroglucinol derivatives. Regarding monomeric phloroglucinols, this group encompasses acryl phloroglucinols, phloroglucinol-terpene adducts, phloroglucinol glycosides, halogenated phloroglucinols, prenylated phloroglucinols, and cyclicroup polyketides.Electric Literature of C9H6O6

The author of 《Fabrication of Hydrazone-Linked Covalent Organic Frameworks Using Alkyl Amine as Building Block for High Adsorption Capacity of Metal Ions》 were Li, Ya; Wang, Chang; Ma, Shujuan; Zhang, Haiyang; Ou, Junjie; Wei, Yinmao; Ye, Mingliang. And the article was published in ACS Applied Materials & Interfaces in 2019. Electric Literature of C9H6O6 The author mentioned the following in the article:

There are several researches on the preparation and application of hydrazone-linked covalent organic frameworks (COFs), and all of them generally necessitate rigid aromatic amines. Herein, we report a strategy for design and synthesis of COF with flexible alkyl amine as a building block and intramol. hydrogen bonding as a knot in the network. The proof-of-concept design was demonstrated by exploring 1,3,5-triformylphloroglucinol and oxalyldihydrazide (ODH) as precursors to synthesize a novel COF material (TpODH), in which different organic building units are combined through hydrazone bonds to form two-dimensional porous frameworks. It should be pointed that irreversible enol-to-keto tautomerism and intramol. N-H···O=C hydrogen bonding of TpODH would enhance the crystallinity and chem. stability, leading to large sp. surface area of 835 m2 g-1. However, another COF synthesized with 1,3,5-triformylbenzene and ODH exhibited less crystallinity and low special surface area (94 m2 g-1). Representatively, the resulting TpODH afforded Cu(II) and Hg(II) capacities of 324 and 1692 mg g-1, resp., which exceeded that of most COFs previously reported. Moreover, the Fourier-transform IR and XPS spectra analyses were taken to demonstrate the adsorption mechanism. These results suggested that the materials could be applied to the removal of metallic ions in the future. In the experiment, the researchers used many compounds, for example, 2,4,6-Trihydroxybenzene-1,3,5-tricarbaldehyde(cas: 34374-88-4Electric Literature of C9H6O6)

2,4,6-Trihydroxybenzene-1,3,5-tricarbaldehyde(cas: 34374-88-4) is a member of phloroglucinol derivatives. Regarding monomeric phloroglucinols, this group encompasses acryl phloroglucinols, phloroglucinol-terpene adducts, phloroglucinol glycosides, halogenated phloroglucinols, prenylated phloroglucinols, and cyclicroup polyketides.Electric Literature of C9H6O6

Referemce:
Alcohol – Wikipedia,
Alcohols – Chemistry LibreTexts

Taha, Muhammad’s team published research in Arabian Journal of Chemistry in 2019 | CAS: 100-83-4

3-Hydroxybenzaldehyde(cas: 100-83-4) can be used as a reactant along with ethyl acetoacetate and thiourea in the synthesis of corresponding dihydropyrimidine-2-thione (monastrol), using Yb(OTf)3 as a catalyst by Biginelli cyclocondensation reaction.SDS of cas: 100-83-4

The author of 《Antiglycation and antioxidant potential of novel imidazo[4,5-b]pyridine benzohydrazones》 were Taha, Muhammad; Alkadi, Khaled A. A.; Ismail, Nor Hadiani; Imran, Syahrul; Adam, Aishah; Kashif, Syed Muhammad; Shah, Syed Adnan Ali; Jamil, Waqas; Sidiqqui, Salman; Khan, Khalid Mohammed. And the article was published in Arabian Journal of Chemistry in 2019. SDS of cas: 100-83-4 The author mentioned the following in the article:

A series consisting of 30 novel imidazo[4,5-b]pyridine benzohydrazones I [R1 = C5H4N, 4-FC6H4, 2,4-(HO)2C6H3, etc.] was synthesized and evaluated for their antiglycation activity as well as their antioxidative potential. The synthetic part involved a 3-step reaction in which a pyridine diamine was converted into a imidazo[4,5-b]pyridine, which was then subjected through another reaction to yield benzohydrazide. Subsequently, the attained benzohydrazide of imidazo[4,5-b]pyridine was used to synthesize the target mols. after treating them with the appropriate benzohydrazone derivatives The derivatives were evaluated for the antiglycation and antioxidant activities. Result obtained showed that di and trihydroxy substituted compounds showed good activity with compound I [R1 = 2,4,6-(HO)3C6H2] (140.16 ± 0.36μM) having the most potent antiglycation activity, which is twice lower than Rutin. The results also showed certain correlation between antiglycation activities with DPPH radical scavenging model as well as FRAP which indicated the participation of antioxidative effect in inhibiting glycation activity. In the part of experimental materials, we found many familiar compounds, such as 3-Hydroxybenzaldehyde(cas: 100-83-4SDS of cas: 100-83-4)

3-Hydroxybenzaldehyde(cas: 100-83-4) can be used as a reactant along with ethyl acetoacetate and thiourea in the synthesis of corresponding dihydropyrimidine-2-thione (monastrol), using Yb(OTf)3 as a catalyst by Biginelli cyclocondensation reaction.SDS of cas: 100-83-4

Referemce:
Alcohol – Wikipedia,
Alcohols – Chemistry LibreTexts

Dong, Bin’s team published research in Materials Chemistry and Physics in 2019 | CAS: 34374-88-4

2,4,6-Trihydroxybenzene-1,3,5-tricarbaldehyde(cas: 34374-88-4) is a member of phloroglucinol derivatives. Regarding monomeric phloroglucinols, this group encompasses acryl phloroglucinols, phloroglucinol-terpene adducts, phloroglucinol glycosides, halogenated phloroglucinols, prenylated phloroglucinols, and cyclicroup polyketides.COA of Formula: C9H6O6

The author of 《Ionic liquid as a green solvent for ionothermal synthesis of 2D keto-enamine-linked covalent organic frameworks》 were Dong, Bin; Wang, Wen-Jing; Pan, Wei; Kang, Guo-Jun. And the article was published in Materials Chemistry and Physics in 2019. COA of Formula: C9H6O6 The author mentioned the following in the article:

Covalent organic frameworks (COFs) are usually synthesized under solvothermal conditions in a mixture of high-boiling organic solvents in a sealed system. By using a room temperature ionic liquid (IL) as a solvent, we presented the preparation of two-dimensional (2D) keto-enamine-linked COFs in an open container at ambient pressure. The as-synthesized 2D keto-enamine-linked COFs have ordered open channels and so the IL can be completely removed from the pores to provide the sole formation of crystalline 2D COFs. Not only the imidazolium-based IL acted as both solvent and catalyst, it was also recycled for further use without activity loss. The experimental part of the paper was very detailed, including the reaction process of 2,4,6-Trihydroxybenzene-1,3,5-tricarbaldehyde(cas: 34374-88-4COA of Formula: C9H6O6)

2,4,6-Trihydroxybenzene-1,3,5-tricarbaldehyde(cas: 34374-88-4) is a member of phloroglucinol derivatives. Regarding monomeric phloroglucinols, this group encompasses acryl phloroglucinols, phloroglucinol-terpene adducts, phloroglucinol glycosides, halogenated phloroglucinols, prenylated phloroglucinols, and cyclicroup polyketides.COA of Formula: C9H6O6

Referemce:
Alcohol – Wikipedia,
Alcohols – Chemistry LibreTexts

Chen, Zhen’s team published research in Journal of Medicinal Chemistry in 2019 | CAS: 18621-18-6

Azetidin-3-ol hydrochloride(cas:18621-18-6) is one of azetidine.Azetidines (azacyclobutanes) constitute a well-known class of heterocyclic compounds. Azetidine scaffold has been discovered in several natural products.Related Products of 18621-18-6 Several pharmacologically important synthetic compounds also contain azetidine ring. Because of inherent ring strain, the synthesis of azetidines is a challenging endeavor.

The author of 《Design, Synthesis, and Evaluation of Reversible and Irreversible Monoacylglycerol Lipase Positron Emission Tomography (PET) Tracers Using a “”Tail Switching”” Strategy on a Piperazinyl Azetidine Skeleton》 were Chen, Zhen; Mori, Wakana; Deng, Xiaoyun; Cheng, Ran; Ogasawara, Daisuke; Zhang, Genwei; Schafroth, Michael A.; Dahl, Kenneth; Fu, Hualong; Hatori, Akiko; Shao, Tuo; Zhang, Yiding; Yamasaki, Tomoteru; Zhang, Xiaofei; Rong, Jian; Yu, Qingzhen; Hu, Kuan; Fujinaga, Masayuki; Xie, Lin; Kumata, Katsushi; Gou, Yuancheng; Chen, Jingjin; Gu, Shuyin; Bao, Liang; Wang, Lu; Collier, Thomas Lee; Vasdev, Neil; Shao, Yihan; Ma, Jun-An; Cravatt, Benjamin F.; Fowler, Christopher; Josephson, Lee; Zhang, Ming-Rong; Liang, Steven H.. And the article was published in Journal of Medicinal Chemistry in 2019. Related Products of 18621-18-6 The author mentioned the following in the article:

Monoacylglycerol lipase (MAGL) is a serine hydrolase that degrades 2-arachidonoylglycerol (2-AG) in the endocannabinoid system (eCB). Selective inhibition of MAGL has emerged as a potential therapeutic approach for the treatment of diverse pathol. conditions, including chronic pain, inflammation, cancer, and neurodegeneration. Herein, we disclose a novel array of reversible and irreversible MAGL inhibitors by means of “”tail switching”” on a piperazinyl azetidine scaffold. We developed a lead irreversible-binding MAGL inhibitor 8 and reversible-binding compounds 17 and 37, which are amenable for radiolabeling with 11C or 18F. [11C]8 ([11C]MAGL-2-11) exhibited high brain uptake and excellent binding specificity in the brain toward MAGL. Reversible radioligands [11C]17 ([11C]PAD) and [18F]37 ([18F]MAGL-4-11) also demonstrated excellent in vivo binding specificity toward MAGL in peripheral organs. This work may pave the way for the development of MAGL-targeted positron emission tomog. tracers with tunability in reversible and irreversible binding mechanisms. In the part of experimental materials, we found many familiar compounds, such as Azetidin-3-ol hydrochloride(cas: 18621-18-6Related Products of 18621-18-6)

Azetidin-3-ol hydrochloride(cas:18621-18-6) is one of azetidine.Azetidines (azacyclobutanes) constitute a well-known class of heterocyclic compounds. Azetidine scaffold has been discovered in several natural products.Related Products of 18621-18-6 Several pharmacologically important synthetic compounds also contain azetidine ring. Because of inherent ring strain, the synthesis of azetidines is a challenging endeavor.

Referemce:
Alcohol – Wikipedia,
Alcohols – Chemistry LibreTexts

Dong, Jianyang’s team published research in Journal of Organic Chemistry in 2019 | CAS: 821-41-0

5-Hexen-1-ol(cas: 821-41-0) is used in cyclization to a tetrahydropyran by phenylselenoetherification. It is also used as a building block in synthetic chemistry.Quality Control of 5-Hexen-1-ol

The author of 《Metal-, Photocatalyst-, and Light-Free Minisci C-H Alkylation of N-Heteroarenes with Oxalates》 were Dong, Jianyang; Wang, Zhen; Wang, Xiaochen; Song, Hongjian; Liu, Yuxiu; Wang, Qingmin. And the article was published in Journal of Organic Chemistry in 2019. Quality Control of 5-Hexen-1-ol The author mentioned the following in the article:

Herein, the authors report a mild protocol for metal-, photocatalyst-, and light-free Minisci C-H alkylation reactions of N-heteroarenes with alkyl oxalates derived from primary, secondary, and tertiary alcs. The protocol uses environmentally benign persulfate as a stoichiometric oxidant and does not require high temperatures or large excesses of either of the substrates, making the procedure suitable for late-stage C-H alkylation of complex mols. Notably, several pharmaceuticals and natural products could be functionalized or prepared with this protocol, thus demonstrating its utility.5-Hexen-1-ol(cas: 821-41-0Quality Control of 5-Hexen-1-ol) was used in this study.

5-Hexen-1-ol(cas: 821-41-0) is used in cyclization to a tetrahydropyran by phenylselenoetherification. It is also used as a building block in synthetic chemistry.Quality Control of 5-Hexen-1-ol

Referemce:
Alcohol – Wikipedia,
Alcohols – Chemistry LibreTexts

Garcia-Vazquez, Rocio’s team published research in Applied Clay Science in 2020 | CAS: 7748-36-9

Oxetan-3-ol(cas: 7748-36-9) is used as a reagent in the synthesis of 5-fluoro-4,6-dialkoxypyrimidine GPR119 agonists. It is also used as a reagent in the synthesis of cyclic sulfone hydroxyethylamines as potent and selective β-site APP-cleaving enzyme 1 (BACE1) inhibitors.Related Products of 7748-36-9

《Clay-based hybrids for controlled release of 7-azaindole derivatives as neuroprotective drugs in the treatment of Alzheimer’s disease》 was published in Applied Clay Science in 2020. These research results belong to Garcia-Vazquez, Rocio; Rebitski, Ediana P.; Viejo, Lucia; de los Rios, Cristobal; Darder, Margarita; Garcia-Frutos, Eva M.. Related Products of 7748-36-9 The article mentions the following:

Hybrid systems based on clay minerals and 7-azaindole derivatives, which show an interesting neuroprotective profile in several in vitro models of neurodegeneration, were developed in order to facilitate the oral administration of these drugs in the treatment of Alzheimer’s disease and provide a controlled release. Two 7-azaindole derivatives with different substitution at position 5 (-OCH3, -H) were synthesized and adsorbed on nanocarriers of different morphol., the lamellar clay montmorillonite (MMT) and the halloysite nanotubes (HNT). Studies carried out in cultures of human neuroblastoma cells confirmed the lack of toxicity of the hybrids and their neuroprotective effect against okadaic acid (OA), the inhibitor of the protein phosphatase 2A (PP2A), similarly to the non-encapsulated drugs. The release assays carried out in systems that simulate the gastrointestinal tract show a rapid release of the drugs from the hybrid materials, making necessary their encapsulation in a protective biopolymer matrix to slow down the release kinetics. A blend of alginate and zein was chosen for this purpose, exploiting the gelation of alginate with calcium ions to process the material as microbeads and the hydrophobic character of zein to reduce the water uptake of the material. Therefore, these bio-nanocomposite systems integrating the drug/clay hybrids seem promising for the oral administration of drugs with multitarget activity for the treatment of Alzheimer’s disease. In addition to this study using Oxetan-3-ol, there are many other studies that have used Oxetan-3-ol(cas: 7748-36-9Related Products of 7748-36-9) was used in this study.

Oxetan-3-ol(cas: 7748-36-9) is used as a reagent in the synthesis of 5-fluoro-4,6-dialkoxypyrimidine GPR119 agonists. It is also used as a reagent in the synthesis of cyclic sulfone hydroxyethylamines as potent and selective β-site APP-cleaving enzyme 1 (BACE1) inhibitors.Related Products of 7748-36-9

Referemce:
Alcohol – Wikipedia,
Alcohols – Chemistry LibreTexts